Purchase Articles
Showing 33–48 of 157 resultsSorted by latest
-
Projected Ontario budget savings from reduced long-term care utilization due to a disease-modifying Alzheimer’s treatment
Read Article -
Integration within Long-Term Care: A Comparative Analysis of Nova Scotia and British Columbia
Read Article -
Effect of amended Patented Medicine Regulations on industry decisions to launch new drugs in Canada
Read Article -
Opportunities to improve health care processes and services outcomes in Canada
Read Article -
Patented Medicines Expenditure in Canada 1990–2020 7th Edition
Read Article -
Patent term erosion and the availability of new medicines in Canada 2000-2022
Read Article -
Liability issues for the use of artificial intelligence (AI) in health care as a home assistance tool
Read Article -
Waiting for new medicines in Canada, Europe and the United States 2016-2021
Read Article -
Access to new medicines in Canada 2016-2021: Federal-provincial public drug programs and private sector drug plans
Read Article -
The PMPRB: Where Are We Now and What’s Next?
Read Article -
Bringing value to healthcare through ambulatory services
Read Article -
Analysis of interventions addressing the nutrition status of seniors in Ontario
Read Article -
A Dollar a Day May Keep the Doctor Away: Putting Spending on Food and Healthcare on a Scale
Read Article -
Pharmacy scope of practice and access to Opioid Agonist Therapies (OAT) in Canada after COVID-19
Read Article -
Champ d’exercice de la pharmacie et accès aux traitements par agonistes opioïdes (TAO) au Canada après la COVID-19
Read Article -
Why would Canada have the longest wait times for an Alzheimer’s treatment among the G7 countries?
Read Article